Optical Coherence Tomography (OCT) Data Collection Study
1 other identifier
observational
303
1 country
1
Brief Summary
Collect OCT data to evaluate the range and age trend of ocular measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 13, 2012
CompletedFirst Posted
Study publicly available on registry
July 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedResults Posted
Study results publicly available
December 19, 2016
CompletedDecember 19, 2016
September 1, 2016
5 months
July 13, 2012
August 1, 2014
October 26, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Primary Endpoints
The primary endpoints are the structural measurement values of (1) the ONH, (2) the peri-papillary RNFL, and (3) the macula obtained using the Spectralis OCT and the statistical descriptors such as mean, standard deviation, and distribution percentiles.
3 months
Bruch's Membrane Opening - Minimum Rim Area, Global
3 months
Study Arms (1)
Normals
No eye disease.
Eligibility Criteria
No eye disease.
You may qualify if:
- Subject is not an employee of the eye clinic.
- Age ≥18 to 90.
- Able and willing to undergo the test procedures, give consent, and to follow instructions.
- Healthy eye without prior intraocular surgery (except cataract surgery and Lasik) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve.
- Caucasian decent (self-reported).
- Negative history of glaucoma.
- Intraocular pressure ≤21mmHg.
- Best corrected visual acuity ≥0.5.
- Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.
- Normal visual field with Glaucoma Hemifield Test and Mean Deviation within normal limits.
- Clinically normal appearance of the optic disc, with normal appearing neuroretinal rim with respect to color and shape. The optic disc is examined ophthalmoscopically and by evaluation of stereo photographs.
- When both eyes are eligible, both eyes enter the study for inter-eye asymmetry; one randomly selected eye will be used for all other measures.
You may not qualify if:
- Unreliable visual field. The reliability indices should be used as guide as well as the perimetrist's notes.
- Unusable disc stereo photos.
- Inability to undergo the tests.
- Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:
- Retina completely included in image frame,
- Quality Score ≥ 20 in the stored ART mean images, and
- For ONH-R scan: Center position error ≤ 100 μm.
- Note: Inability of a subject to perform one of the two scan patterns or insufficient image quality in one scan pattern does not exclude the subject or eye from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dalhousie University
Halifax, Nova Scotia, B3H 2Y9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Gerhard Zinser, PhD
- Organization
- Heidelberg Engineering GmbH
Study Officials
- PRINCIPAL INVESTIGATOR
Balwantray Chauhan, PhD
Dalhousie University, Halifax, NS, Canada
- PRINCIPAL INVESTIGATOR
Claude Burgoyne, MD
Devers Eye Institute, Portland, OR, USA
- PRINCIPAL INVESTIGATOR
Christopher Girkin, MD
Callahan Eye Foundation Hospital, Birmingham, AL, USA
- PRINCIPAL INVESTIGATOR
Christian Mardin, MD
Augenklinik des Universitätsklinikums Erlangen, Erlangen, Germany
- PRINCIPAL INVESTIGATOR
Alexander Scheuerle, MD
Universitätsaugenklinik, Heidelberg, Germany
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2012
First Posted
July 17, 2012
Study Start
July 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
December 19, 2016
Results First Posted
December 19, 2016
Record last verified: 2016-09